alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
## Breadcrumb

-  Home 

# Explore Search: Atmospheres

Filters

              - science_faqs(4)
              - science_science(189)
              - products_data(130)
              - products_maps(16)
              - products_publications(2007)
              - products_software(7)
              - products_web_tools(8)
              - multimedia_audio(82)
              - multimedia_audio-141766(78)
              - multimedia_audio-141767(4)
              - multimedia_before_after(5)
              - multimedia_image(196)
              - multimedia_image-141769(1)
              - multimedia_image-141770(4)
              - multimedia_image-141771(145)
              - multimedia_image-141772(4)
              - multimedia_image-141774(2)
              - multimedia_image-141775(22)
              - multimedia_image-141776(16)
              - multimedia_image-204460(2)
              - (-)multimedia_slideshow(2)
              - multimedia_video(229)
              - multimedia_video-149194(87)
              - multimedia_video-149195(54)
              - multimedia_video-149196(16)
              - multimedia_video-149197(15)
              - multimedia_video-149198(13)
              - multimedia_video-149225(2)
              - documents_file(10)
              - documents_file-149204(1)
              - documents_file-149213(1)
              - documents_file-149214(4)
              - documents_file-149218(1)
              - documents_file-149220(1)
              - documents_file-149222(1)
              - news_news-149245(2)
              - news_news-149246(2)
              - news_news-149248(5)
              - news_news-149249(2)
              - news_news-149250(7)
              - (-)news_newsletters(2)
              - news_other_news(36)
              - connect_staff_profiles(23)
              - other_basic-37(3)
              - other_basic-42(16)

## By Location

              - colorado(1)
              - idaho(1)
              - wyoming(1)

## By Year

newsletter        January 10, 2022      The Monitor newsletter - Vol. 5 | Issue Winter 2022

newsletter        October 5, 2023      Latest in Landsat - October 2023 - Vol. 2 | Issue 10

slideshow        December 22, 2022        Desert, aquatic, prairie, forest, riparian, tundra, and sagebrush plants

slideshow        September 23, 2021        Rocky Mountain Regional Snowpack Chemistry Photo Gallery
Exhibit 32.1

Certification of Principal Executive Officer

Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002 (18 U.S.C. Section 1350)

In connection with the Quarterly Report on Form 10-Q for the quarter ended March 31, 2009 (the
Report) of UTEK Corporation (the Registrant), as filed with the Securities and Exchange Commission on the date hereof, I, Douglas Schaedler, the Principal Executive Officer of the Registrant, hereby certify, to the best of my
knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Registrant.



|                       
|-----------------------
|/s/ Douglas Schaedler  
|Name: Douglas Schaedler
|Date: May 8, 2009
# C_2020317EN.01002401.xml

| 25.9.2020 | EN | Official Journal of the European Union | C 317/24 |
| --- | --- | --- | --- |

25.9.2020

EN

Official Journal of the European Union

C 317/24

---

Prior notification of a concentration

(Case M.9962 — Mylan/Aspen’s EU Thrombosis Business)

(Text with EEA relevance)

(2020/C 317/08)

1.

This notification concerns the following undertakings:

| — | Mylan Ireland Limited (‘Mylan’, Ireland), |
| --- | --- |

—

Mylan Ireland Limited (‘Mylan’, Ireland),

| — | Aspen’s EU Thrombosis Business (the ‘Target’, Mauritius), belonging to the group Aspen Pharmacare Holdings LTD. |
| --- | --- |

—

Aspen’s EU Thrombosis Business (the ‘Target’, Mauritius), belonging to the group Aspen Pharmacare Holdings LTD.

Mylan acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of the Target. The concentration is accomplished by way of purchase of assets.

2.

| — | Mylan develops, licenses, manufactures, markets and distributes generic, branded generic and speciality pharmaceuticals in addition to OTC and consumer healthcare products; |
| --- | --- |

—

Mylan develops, licenses, manufactures, markets and distributes generic, branded generic and speciality pharmaceuticals in addition to OTC and consumer healthcare products;

| — | The Target comprises certain commercialisation rights and related intellectual property rights of Aspen’s antithrombotic products in the EEA, namely the molecules Nadroparin (brand names Fraxiparine and Fraxodi), Fondaparinux (brand name Arixtra), Certoparin (brand name Mono Embolex) and Danaparoid (brand name Orgaran). |
| --- | --- |

—

The Target comprises certain commercialisation rights and related intellectual property rights of Aspen’s antithrombotic products in the EEA, namely the molecules Nadroparin (brand names Fraxiparine and Fraxodi), Fondaparinux (brand name Arixtra), Certoparin (brand name Mono Embolex) and Danaparoid (brand name Orgaran).

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9962 — Mylan/Aspen’s EU Thrombosis Business

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 556 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 556

    To amend title XVIII of the Social Security Act to add physical 
  therapists to the list of providers allowed to utilize locum tenens 
          arrangements under Medicare, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 27, 2015

   Mr. Bilirakis (for himself, Mr. Ben Ray Lujaan of New Mexico, Mr. 
Tonko, Mr. Kelly of Pennsylvania, Mr. Pompeo, Mr. King of Iowa, and Mr. 
   Meehan) introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   Ways and Means, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 
    To amend title XVIII of the Social Security Act to add physical 
  therapists to the list of providers allowed to utilize locum tenens 
          arrangements under Medicare, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Prevent Interruptions in Physical 
Therapy Act of 2015''.

SEC. 2. ALLOWING PHYSICAL THERAPISTS TO UTILIZE LOCUM TENENS 
              ARRANGEMENTS UNDER MEDICARE.

    (a) In General.--The first sentence of section 1842(b)(6) of the 
Social Security Act (42 U.S.C. 1395u(b)(6)) is amended--
            (1) by striking ``and'' before ``(H)''; and
            (2) by inserting before the period at the end the 
        following: ``, and (I) in the case of outpatient physical 
        therapy services furnished by physical therapists, subparagraph 
        (D) of this sentence shall apply to such services and 
        therapists in the same manner as such subparagraph applies to 
        physicians' services furnished by physicians''.
    (b) Effective Date.--The amendments made by subsection (a) shall 
apply to services furnished after the date of the enactment of this 
Act.
                                 <all>
```
Donald ECHOLS, Appellant, v. STATE of Florida, Appellee.

Case No. 2D18-903

District Court of Appeal of Florida, Second District.

Opinion filed September 12, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
EXHIBIT 13.1



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT



Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer
of Petrobras International Finance CompanyPIFCo (the Company), does hereby certify, to such officers knowledge, that:



The Annual Report on Form 20-F for the year ended December 31, 2003 of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities and
Exchange Act of 1934 and information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                    |  |        |  |                             
|------------------- |  | ------ |  | ----------------------------
|                    |  | By:    |  | /s/ ALMIR GUILHERME BARBASSA
|Date: June 30, 2004 |  | Name:  |  | Almir Guilherme Barbassa    
|                    |  | Title: |  | Chairman                    



A signed original of this written
statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.



---

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT



Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer
of Petrobras International Finance CompanyPIFCo (the Company), does hereby certify, to such officers knowledge, that:



The Annual Report on Form 20-F for the year ended December 31, 2003 of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities and
Exchange Act of 1934 and information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                    |  |        |  |                            
|------------------- |  | ------ |  | ---------------------------
|Date: June 30, 2004 |  | By:    |  | /s/ DANIEL LIMA DE OLIVEIRA
|                    |  | Name:  |  | Daniel Lima de Oliveira    
|                    |  | Title: |  | Financial Manager          



A signed original of this written
statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
Digna ZORRILLA, Appellant, v. Evelyn Leonardo FERNANDEZ, Appellee.

Case No. 2D17-2453

District Court of Appeal of Florida, Second District.

Opinion filed August 24, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
## Breadcrumb

-  Home 

# Explore Search: Declination

Filters

              - science_science(1)
              - products_publications(4)
              - multimedia_image(3)
              - (-)multimedia_image-141771(3)
              - news_other_news(1)

## By Location

              - alaska(6)
              - arizona(2)
              - california(6)
              - delaware(1)
              - florida(2)
              - hawaii(4)
              - iowa(1)
              - kansas(1)
              - louisiana(1)
              - nevada(1)
              - (-)u.s. virgin islands(3)
              - utah(1)
              - washington(3)

## By Year

Photography        March 21, 2009        A Diversity of Corals Growing in the Mangroves Within Virgin Islands Coral Reef National Monument

Photography        March 21, 2009        A Diversity of Corals Growing in the Mangroves Within Virgin Islands Coral Reef National Monument

Photography        December 31, 2008        A Queen Angelfish Swims in Front of Coral Colonies of Several Species Growing in Mangroves Within Virgin Islands Coral Reef National Monument
xml version="1.0" encoding="UTF-8"?


C\_2020338EN.01000401.xml


| | | | |
| --- | --- | --- | --- |
| 12.10.2020 | EN | Official Journal of the European Union | C 338/4 |

---

Prior notification of a concentration

(Case M.9986 — KPS Capital Partners/Garrett Motion)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 338/04)

1.

On 2 October 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2020338EN.01000401-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | KPS Capital Partners, LP (‘KPS’, USA), |

| | |
| --- | --- |
| — | Garrett Motion, Inc. (‘Garrett’, USA). |

KPS acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Garrett. The concentration is accomplished by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

| | |
| --- | --- |
| — | for KPS: managing a series of funds which invest in manufacturing and industrial companies across an array of industries, including basic materials, branded consumer, healthcare and luxury products, automotive parts, capital equipment and general manufacturing, |

| | |
| --- | --- |
| — | for Garrett: designing, manufacturing and selling turbochargers, electric-boosting and connected vehicle technologies for Original Equipment Manufacturers and the aftermarket. |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 [(2)](#ntr2-C_2020338EN.01000401-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9986 — KPS Capital Partners/Garrett Motion

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| |
| --- |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2020338EN.01000401-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

[(2)](#ntc2-C_2020338EN.01000401-E0002)  [OJ C 366, 14.12.2013, p. 5](http://publications.europa.eu/resource/oj/JOC_2013_366_R_TOC).

---
[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT

________________________

No. 15-14895

Non-Argument Calendar

________________________

D.C. Docket No. 0:15-cv-62176-WPD; 0:99-cr-06064-WPD-1

ROBERT MARVIN HARRIS, 

 Petitioner-Appellant, 

versus

UNITED STATES OF AMERICA, 

 Respondent-Appellee.

________________________

Appeal from the United States District Court

for the Southern District of Florida

________________________

(June 29, 2016)

Before WILLIAM PRYOR, MARTIN and ANDERSON, Circuit Judges.

PER CURIAM: 

Case: 15-14895 Date Filed: 06/29/2016 Page: 1 of 3 
2

Robert Harris appeals pro se the dismissal of his second motion to vacate. 28 

U.S.C. § 2255. The district court dismissed Harris’s motion for failure to obtain 

leave to file a second or successive motion. 28 U.S.C. §§ 2244(b)(3)(A), 2255(h). 

We affirm.

Harris has waived any challenge that he could have made to the dismissal of 

his second motion to vacate. The district court “[d]ismissed [Harris’s motion] as 

successive” and instructed him to “petition the Eleventh Circuit for permission to 

file a successive motion.” But Harris disregarded his obligation to file “the 

appropriate form provided by the clerk of this court” to request leave to file a 

successive motion. See 11th Cir. R. 22-3(a); Moton v. Cowart, 631 F.3d 1337, 

1340 n.2 (11th Cir. 2011) (requiring pro se litigants “to conform to procedural 

rules”). The district court was required to dismiss Harris’s motion sua sponte

because, “[w]ithout authorization, the district court lacks jurisdiction to consider a

second or successive [motion].” United States v. Holt, 417 F.3d 1172, 1175 (11th 

Cir. 2005). Because Harris does not dispute that his motion is barred as successive, 

we deem abandoned any challenge that he could have made to the dismissal of his 

motion. See Timson v. Sampson, 518 F.3d 870, 874 (11th Cir. 2008). Harris argues 

in his reply brief for “this Court [to] liberally construe [his] [initial] brief as an 

implied petition to file a second or successive . . . motion,” but our precedent holds 

Case: 15-14895 Date Filed: 06/29/2016 Page: 2 of 3 
3

that “we do not address arguments raised for the first time in a pro se litigant’s 

reply brief,” id.

We AFFIRM the dismissal of Harris’s second motion to vacate.

Case: 15-14895 Date Filed: 06/29/2016 Page: 3 of 3
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          64,320
<SECURITIES>                                         0
<RECEIVABLES>                                  734,219
<ALLOWANCES>                                   143,493
<INVENTORY>                                  1,668,821
<CURRENT-ASSETS>                             3,071,676
<PP&E>                                       1,487,137
<DEPRECIATION>                                 489,066
<TOTAL-ASSETS>                               5,195,429
<CURRENT-LIABILITIES>                        3,913,096
<BONDS>                                              0
<PREFERRED-MANDATORY>                        1,500,000
<PREFERRED>                                          0
<COMMON>                                        30,000
<OTHER-SE>                                   (663,152)
<TOTAL-LIABILITY-AND-EQUITY>                 5,195,429
<SALES>                                      2,878,036
<TOTAL-REVENUES>                             2,878,036
<CGS>                                        1,751,898
<TOTAL-COSTS>                                1,751,898
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             130,608
<INCOME-PRETAX>                               (31,691)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (31,691)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (31,691)
<EPS-BASIC>                                      (.01)
<EPS-DILUTED>                                    (.01)


</TABLE>
# C_2020412EN.01000201.xml

| 30.11.2020 | EN | Official Journal of the European Union | C 412/2 |
| --- | --- | --- | --- |

30.11.2020

EN

Official Journal of the European Union

C 412/2

---

Non-opposition to a notified concentration

(Case M.9946 — MSI/Altice/Lightpath)

(Text with EEA relevance)

(2020/C 412/02)

On 20 October 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9946. EUR-Lex is the on-line access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9946. EUR-Lex is the on-line access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---